Literature DB >> 9762028

Bullous pemphigoid. The latest in diagnosis, prognosis, and therapy.

N J Korman.   

Abstract

Mesh：

Year:  1998        PMID： 9762028     DOI： 10.1001/archderm.134.9.1137

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN： 0003-987X


× No keyword cloud information.
  9 in total

Review 1.  Bullous pemphigoid: from bench to bedside.

Authors:  Scott R A Walsh; David Hogg; P Régine Mydlarski
Journal:  Drugs       Date:  2005       Impact factor: 9.546

Review 2.  The role of topical corticosteroids in bullous pemphigoid in the elderly.

Authors:  Pascal Joly; Juliette Fontaine; Jean-Claude Roujeau
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

3.  Up-regulation of CCL11 and CCL26 is associated with activated eosinophils in bullous pemphigoid.

Authors:  C Günther; G Wozel; M Meurer; C Pfeiffer
Journal:  Clin Exp Immunol       Date:  2011-11       Impact factor: 4.330

4.  How Do Experts Treat Patients with Bullous Pemphigoid around the World? An International Survey.

Authors:  Marine Guignant; Billal Tedbirt; Dedee F Murrell; Masayuki Amagai; Valeria Aoki; Johannes Bauer; Giuseppe Ciancinni; Donna Culton; Maryam Daneshpazhooh; Dipankar De; Janet Fairley; Russell Hall; Soo-Chan Kim; Neil J Korman; Cezary Kowalewski; Daniel Mimouni; Aikaterini Patsatsi; Vivien Hebert; Marwah Adly Mohamed Saleh; Enno Schmidt; Eli Sprecher; Soner Uzun; Vanessa Venning; Victoria P Werth; Detlef Zillikens; Pascal Joly
Journal:  JID Innov       Date:  2022-04-12

5.  Role of methotrexate in the treatment of bullous pemphigoid in the elderly.

Authors:  Timothy Patton; Neil Korman
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923

6.  Incidence of bullous pemphigoid and mortality of patients with bullous pemphigoid in Olmsted County, Minnesota, 1960 through 2009.

Authors:  Katherine E Brick; Chad H Weaver; Christine M Lohse; Mark R Pittelkow; Julia S Lehman; Michael J Camilleri; Mustafa Al-Hashimi; Carilyn N Wieland
Journal:  J Am Acad Dermatol       Date:  2014-04-03       Impact factor: 11.527

7.  Treatment of oral pemphigoid with intravenous immunoglobulin as monotherapy. Long-term follow-up: influence of treatment on antibody titres to human alpha6 integrin.

Authors:  N Sami; K C Bhol; A R Ahmed
Journal:  Clin Exp Immunol       Date:  2002-09       Impact factor: 4.330

8.  A 74-year-old woman with a 1-month history of itching and skin rash.

Authors:  Sujoy Ghosh; Arjun K Ghosh; Andrew Collier
Journal:  Ann Saudi Med       Date:  2009 May-Jun       Impact factor: 1.526

9.  Bullous pemphigoid and comorbidities: a case-control study in Portuguese patients.

Authors:  Vera Barreto Teixeira; Rita Cabral; Maria Manuel Brites; Ricardo Vieira; Américo Figueiredo
Journal:  An Bras Dermatol       Date:  2014 Mar-Apr       Impact factor: 1.896
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.